Xueting Fan
National Key Laboratory Of Intelligent Tracking And Forecasting For Infectious Diseases
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
mRNA mediated expression of novel fusion phage tail protein with antimicrobial peptides inside macrophages for targeted clearance of intracellular Mycobacterium tuberculosis.
Journal: Emerging microbes & infections
Published: February 03, 2026
Protective Effect and Immune Mechanism of EPCP009 Booster Immunization after BCG Prime Immunization Against Tuberculosis in Mice - China, 2024.
Journal: China CDC weekly
Published: July 01, 2025
Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in cervical cancer.
Journal: Cell death & disease
Published: July 05, 2024
A novel pathogenic species of genus Stenotrophomonas: Stenotrophomonas pigmentata sp. nov.
Journal: Frontiers in cellular and infection microbiology
Published: April 01, 2024
Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice.
Journal: Human vaccines & immunotherapeutics
Published: January 23, 2024
Reactivation of methylation-silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway.
Journal: Molecular carcinogenesis
Published: December 12, 2023
Exploring the immunogenicity of Rv2201-519: A T-cell epitope-based antigen derived from Mycobacterium tuberculosis AsnB with implications for tuberculosis infection detection and vaccine development.
Journal: International immunopharmacology
Published: October 13, 2023
Comparison of the Immunogenicity and Efficacy of rBCG-EPCP009, BCG Prime-EPCP009 Booster, and EPCP009 Protein Regimens as Tuberculosis Vaccine Candidates.
Journal: Vaccines
Published: October 10, 2023
A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses.
Journal: Frontiers in immunology
Published: August 13, 2023
A novel multi-component protein vaccine ECP001 containing a protein polypeptide antigen nPstS1 riching in T-cell epitopes showed good immunogenicity and protection in mice.
Journal: Frontiers in immunology
Published: January 06, 2023
Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates.
Journal: Vaccine
Published: November 17, 2022
Last Updated: 09/26/2026